“To survive, community pharmacies are evolving beyond the traditional “product-dispensing” revenue model. The future of local pharmacy relies on diversifying revenue away from product margin alone—shifting toward clinical service delivery, point-of-care testing, specialized compounding, disease state management, and direct-care service contracts with local employers and health plans” – Erin Albert
Continue reading The Future of Community Pharmacies
Watch Real Experiences and Insights from Employers, Employees and Brokers
Wondering what ICHRA looks like in practice? Hear testimonials directly from employers, employees, and brokers as they share real experiences with Individual Coverage Health Reimbursement Arrangements (ICHRAs), offering practical insights, lessons learned, and perspectives on personalized health coverage, employee choice, and cost control.
Continue reading ICHRA Stories
This is Part 6 of a 6 Part Series By Erin L. Albert, MBA, PharmD, JD, DASPL
“To understand why a medication costs $10 for one person and $1,000 for another under the exact same plan design, one must examine how drug formularies handle money at the counter—and how modern pricing structures, like the Mark Cuban Cost Plus Drug Company (MCCPDC) bolt-on model, attempt to disrupt that framework.”
Continue reading The Life of a Prescription in the USA in 2026–Drug Formularies, Pricing, and Money at the Pharmacy Counter